BTAIQ(BioXcel Therapeutics, Inc.) 的内部人交易:医疗保健,特药与仿制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-05-20 | Yocca Frank | Chief Scientific Officer | 公开市场卖出 | 6,845 | $1.08 |
| 2026-05-20 | Rodriguez Javier | See Remarks | 公开市场卖出 | 6,560 | $1.08 |
| 2026-05-20 | Steinhart Richard I | Chief Financial Officer | 公开市场卖出 | 6,845 | $1.08 |
| 2026-05-20 | Mehta Vimal | CEO and President | 公开市场卖出 | 19,419 | $1.09 |
| 2024-12-16 | O'Neill Vincent | See Remarks | 公开市场卖出 | 165 | $0.35 |
| 2024-12-16 | Mehta Vimal | CEO and President | 公开市场卖出 | 2,134 | $0.36 |
| 2024-12-16 | Mehta Vimal | CEO and President | 公开市场卖出 | 983 | $0.36 |
| 2024-12-16 | Steinhart Richard I | Chief Financial Officer | 公开市场卖出 | 372 | $0.36 |
| 2024-12-16 | Steinhart Richard I | Chief Financial Officer | 公开市场卖出 | 205 | $0.36 |
| 2024-12-16 | Rodriguez Javier | See Remarks | 公开市场卖出 | 220 | $0.36 |
| 2024-12-16 | Rodriguez Javier | See Remarks | 公开市场卖出 | 210 | $0.35 |
| 2024-12-16 | Yocca Frank | Chief Scientific Officer | 公开市场卖出 | 225 | $0.35 |
| 2024-12-16 | Yocca Frank | Chief Scientific Officer | 公开市场卖出 | 205 | $0.36 |